Clinicodemographic Profiles of Rheumatoid Arthritis Patients from a Single Center in Saudi Arabia

References

• Hansen IMJ, Andreasen RA, van Bui Hansen MN, et al. The reliability of disease activity score in 28 joints–C-reactive protein might be overestimated in a subgroup of rheumatoid arthritis patients, when the score is solely based on subjective parameters: a cross-sectional, exploratory study. J Clin Rheumatol. 2017;23(2):102–106. doi:10.1097/RHU.000000000000046927870649
   PubMed Web of Science ®Google Scholar
• Van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJJ. EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Ann Rheum Dis. 2017;76(3):491–496. doi:10.1136/annrheumdis-2016-20984627991858
   PubMed Web of Science ®Google Scholar
• Kleyer A, Finzel S, Rech J, et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis. 2014;73(5):854–860. doi:10.1136/annrheumdis-2012-20295823520034
   PubMed Web of Science ®Google Scholar
• Xu B, Lin J. Characteristics and risk factors of rheumatoid arthritis in the United States: an NHANES analysis. PeerJ. 2017;5:e4035. doi:10.7717/peerj.403529188142
   PubMed Web of Science ®Google Scholar
• Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73(1):62–68. doi:10.1136/annrheumdis-2013-20422324095940
   PubMed Web of Science ®Google Scholar
• Almoallim HM, Alharbi LA. Rheumatoid arthritis in Saudi Arabia. Saudi Med J. 2014;35:1442–1454.25491208
   PubMed Web of Science ®Google Scholar
• Albishri J, Bukhari M, Alsabban A, et al. Prevalence of RA and SLE in Saudi Arabia. Sch J App Med Sci. 2015;3:2096–2099.
   Google Scholar
• Almoallim H, Janoudi N, Attar SM, et al. Determining early referral criteria for patients with suspected inflammatory arthritis presenting to primary care physicians: a cross-sectional study. Open Access Rheumatol. 2017;9:81–90. doi:10.2147/OARRR.S13478028490909
   PubMed Web of Science ®Google Scholar
• Almuhareb AM, Alhawassi TM, Alghamdi AA, et al. Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia. Saudi Pharm J. 2019;27(7):939–944. doi:10.1016/j.jsps.2019.07.00231997900
   PubMed Web of Science ®Google Scholar
• Dargham SR, Zahirovic S, Hammoudeh M, et al. Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. PLoS One. 2018;13(12):e0208240. doi:10.1371/journal.pone.020824030566451
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.2758420872595
   PubMed Web of Science ®Google Scholar
• Wells G, Becker J, Teng J, et al. Validation of the 28-joint disease activity score (DAS28) and European league against rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009;68:954–960.18490431
   PubMed Web of Science ®Google Scholar
• Bruce B, Fries JF. The health assessment questionnaire (HAQ). Clin Exp Rheumatol. 2005;23:S14–18.16273780
   PubMed Web of Science ®Google Scholar
• El Meidany YM, El Gaafary MM, Ahmed I. Cross-cultural adaptation and validation of an Arabic health assessment questionnaire for use in rheumatoid arthritis patients. Joint Bone Spine. 2003;70(3):195–202. doi:10.1016/S1297-319X(03)00004-612814762
   PubMed Web of Science ®Google Scholar
• Al-Dalaan A, Al Ballaa S, Bahabri S, et al. The prevalence of rheumatoid arthritis in the Qassim region of Saudi Arabia. Ann Saudi Med. 1998;18(5):396–397. doi:10.5144/0256-4947.1998.39617344708
   PubMed Web of Science ®Google Scholar
• Barnabe C, Homik J, Barr SG, et al. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy. J Rheumatol. 2014;41(8):1607–1613. doi:10.3899/jrheum.13145125028371
   PubMed Web of Science ®Google Scholar
• Almoallim H, Hassan R, Cheikh M, et al. Rheumatoid arthritis Saudi database (RASD): disease characteristics and remission rates in a tertiary care center. Open Access Rheumatol. 2020;12:139–145. doi:10.2147/OARRR.S26042632821181
   PubMed Web of Science ®Google Scholar
• Eleishi HH, Toma NF, Chaki MC, et al. Three years experience with the prescription of anti‐TNF‐α inhibitors at Dr Soliman Fakeeh Hospital in Jeddah, Saudi Arabia. Int J Rheum Dis. 2009;12(1):14–19. doi:10.1111/j.1756-185X.2009.01373.x20374311
   PubMed Web of Science ®Google Scholar
• Hetland ML, Christensen IJ, Tarp U, et al. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis Rheum. 2010;62:22–32.20039405
   PubMed Web of Science ®Google Scholar
• Hyrich KL, Watson KD, Lunt M, et al. Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008. Rheumatology (Oxford). 2011;50(1):117–123. doi:10.1093/rheumatology/keq20920671021
   PubMed Web of Science ®Google Scholar
• Manavathongchai S, Bian A, Rho YH, et al. Inflammation and hypertension in rheumatoid arthritis. J Rheumatol. 2013;40(11):1806–1811. doi:10.3899/jrheum.13039423996293
   PubMed Web of Science ®Google Scholar
• Al-Bishri J, Attar S, Bassuni N, et al. Comorbidity profile among patients with rheumatoid arthritis and the impact on prescriptions trend. Clin Med Insights Arthritis Musculoskelet Disord. 2013;6:11–18. doi:10.4137/CMAMD.S1148123645988
   PubMedGoogle Scholar
• England BR, Thiele GM, Anderson DR, et al. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036. doi:10.1136/bmj.k103629685876
   PubMed Web of Science ®Google Scholar
• Mantel Ä, Holmqvist M, Nyberg F, et al. Risk factors for the rapid increase in risk of acute coronary events in patients with new‐onset rheumatoid arthritis: a nested case–control study. Arthritis Rheum. 2015;67(11):2845–2854. doi:10.1002/art.39267
   PubMed Web of Science ®Google Scholar
• Krishnan E, Häkkinen A, Sokka T, et al. Impact of age and comorbidities on the criteria for remission and response in rheumatoid arthritis. Ann Rheum Dis. 2005;64(9):1350–1352. doi:10.1136/ard.2005.03790315760927
   PubMed Web of Science ®Google Scholar
• Horiuchi AC, Pereira LHC, Kahlow BS, et al. Rheumatoid arthritis in elderly and young patients. Rev Bras Reumatol Engl Ed. 2017;57(5):491–494. doi:10.1016/j.rbr.2015.06.00529037323
   PubMedGoogle Scholar
• Innala L, Berglin E, Möller B, et al. Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study. Arthritis Res Ther. 2014;16(2):R94. doi:10.1186/ar454024731866
   PubMed Web of Science ®Google Scholar